Backed by $52 million in Series A financing led by 8VC and named after a feat of engineering in ancient Rome, Appia Bio jumped into the cell therapy fray this morning with a promising scalable technology platform. Read more Other articles News August 12, 2025Solutions to Human & Planetary Challenges with Freeflow – David Fleck News June 11, 2025Captura Gears Up For Commercial Deployment With New HQ In Pasadena News June 10, 2025CNBC DISRUPTOR 50 – Iambic Therapeutics